Short Description
Determines free fatty acid levels through enzymatic acylation.
Development Stage
Research-Grade Metabolic Assay Development
Description
The OXPHOSight™ Free Fatty Acid Assay Kit quantifies circulating lipids to assess insulin resistance, supporting the discovery of drugs targeting lipolysis and fatty acid oxidation. This non-radioactive method enables safe, high-throughput identification of metabolic syndrome targets. It is widely used to evaluate the efficacy of lipid-modulating therapies and to understand the role of fatty acids in metabolic disorders.
Features
Non-radioactive method for safe lipid analysis; Supports high-throughput identification of metabolic syndrome targets and lipolysis regulators.
Process Relevance
Metabolic Syndrome Research
Application Stage
Discovery
Applications
Evaluates lipid metabolism and fatty acid oxidation.
Qualified With
Internal performance validation using reference standards under defined assay conditions.
Detection Method
Absorbance at 570 nm, or Fluorescence Detection (Ex 530 nm / Em 585 nm)
Sample Type
Serum, plasma, urine, saliva, milk, cell cultures, food, agriculture samples
Research Areas
Diabetes & Obesity; Cardiovascular Disease
Datasheet